Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 539

1.

A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers.

Wentzensen N, Walker J, Smith K, Gold MA, Zuna R, Massad LS, Liu A, Silver MI, Dunn ST, Schiffman M.

Am J Obstet Gynecol. 2018 Feb 17. pii: S0002-9378(18)30153-4. doi: 10.1016/j.ajog.2018.02.009. [Epub ahead of print]

PMID:
29462629
2.

A novel metric that quantifies risk stratification for evaluating diagnostic tests: The example of evaluating cervical-cancer screening tests across populations.

Katki HA, Schiffman M.

Prev Med. 2018 Feb 14. pii: S0091-7435(18)30040-9. doi: 10.1016/j.ypmed.2018.02.013. [Epub ahead of print]

PMID:
29454079
3.

The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis.

Mirabello L, Clarke MA, Nelson CW, Dean M, Wentzensen N, Yeager M, Cullen M, Boland JF; NCI HPV Workshop, Schiffman M, Burk RD.

Viruses. 2018 Feb 13;10(2). pii: E80. doi: 10.3390/v10020080.

4.

Clinical outcomes after conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women ages 21-39 years.

Silver MI, Gage JC, Schiffman M, Fetterman B, Poitras NE, Lorey T, Cheung LC, Katki HA, Locke A, Kinney WK, Castle PE.

Cancer Prev Res (Phila). 2018 Feb 5. pii: canprevres.0293.2017. doi: 10.1158/1940-6207.CAPR-17-0293. [Epub ahead of print]

PMID:
29437696
5.

Human Papillomavirus DNA methylation as a biomarker for cervical precancer: Consistency across 12 genotypes and potential impact on management of HPV-positive women.

Clarke MA, Gradíssimo A, Schiffman M, Lam J, Sollecito CC, Fetterman B, Lorey T, Poitras NE, Raine-Bennett T, Castle PE, Wentzensen N, Burk RD.

Clin Cancer Res. 2018 Feb 2. pii: clincanres.3251.2017. doi: 10.1158/1078-0432.CCR-17-3251. [Epub ahead of print]

PMID:
29420222
6.

T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study.

Lang Kuhs KA, Lin SW, Hua X, Schiffman M, Burk RD, Rodriguez AC, Herrero R, Abnet CC, Freedman ND, Pinto LA, Hamm D, Robins H, Hildesheim A, Shi J, Safaeian M.

PLoS One. 2018 Jan 31;13(1):e0178167. doi: 10.1371/journal.pone.0178167. eCollection 2018.

7.

Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies.

Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, Schiffman M, Rodriguez AC, Chanock S, Jimenez S, Schussler J, Gail MH, Safaeian M, Kemp TJ, Cortes B, Pinto LA, Hildesheim A, Gonzalez P; Costa Rica HPV Vaccine Trial (CVT) Group.

Vaccine. 2018 Jan 20. pii: S0264-410X(18)30018-5. doi: 10.1016/j.vaccine.2017.12.078. [Epub ahead of print]

PMID:
29366703
8.

Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer.

Clarke MA, Fetterman B, Cheung LC, Wentzensen N, Gage JC, Katki HA, Befano B, Demarco M, Schussler J, Kinney WK, Raine-Bennett TR, Lorey TS, Poitras NE, Castle PE, Schiffman M.

J Clin Oncol. 2018 Jan 22:JCO2017753442. doi: 10.1200/JCO.2017.75.3442. [Epub ahead of print]

PMID:
29356609
9.

Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61).

Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Chan PKS, Burk RD.

Virology. 2018 Jan 11;516:86-101. doi: 10.1016/j.virol.2018.01.002. [Epub ahead of print]

PMID:
29331867
10.

Accelerating cervical cancer control and prevention.

Wentzensen N, Schiffman M.

Lancet Public Health. 2018 Jan;3(1):e6-e7. doi: 10.1016/S2468-2667(17)30242-6. Epub 2017 Dec 19. No abstract available.

11.

Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting.

Rendle KA, Schiffman M, Cheung LC, Kinney WK, Fetterman B, Poitras NE, Lorey T, Castle PE.

Prev Med. 2017 Dec 27;109:44-50. doi: 10.1016/j.ypmed.2017.12.023. [Epub ahead of print]

PMID:
29288782
12.

Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.

Sailer V, Schiffman MH, Kossai M, Cyrta J, Beg S, Sullivan B, Pua BB, Lee KS, Talenfeld AD, Nanus DM, Tagawa ST, Robinson BD, Rao RA, Pauli C, Bareja R, Beltran LS, Sigaras A, Eng KW, Elemento O, Sboner A, Rubin MA, Beltran H, Mosquera JM.

Cancer. 2018 Mar 1;124(5):1008-1015. doi: 10.1002/cncr.31173. Epub 2017 Dec 19.

PMID:
29266381
13.

Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records.

Landy R, Cheung LC, Schiffman M, Gage JC, Hyun N, Wentzensen N, Kinney WK, Castle PE, Fetterman B, Poitras NE, Lorey T, Sasieni PD, Katki HA.

Prev Med. 2017 Dec 6. pii: S0091-7435(17)30482-6. doi: 10.1016/j.ypmed.2017.12.004. [Epub ahead of print]

14.

Transarterial Embolization of a Bartholin Cyst before Resection.

Cornman-Homonoff J, Pereira N, Fenster TB, Schiffman MH.

J Minim Invasive Gynecol. 2017 Nov 28. pii: S1553-4650(17)31292-X. doi: 10.1016/j.jmig.2017.11.016. [Epub ahead of print] No abstract available.

PMID:
29195798
15.

Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study.

Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Zhao FH, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Katki HA, Schiffman M.

Ann Intern Med. 2018 Jan 2;168(1):20-29. doi: 10.7326/M17-1609. Epub 2017 Nov 28.

PMID:
29181509
16.

Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.

Schiffman M, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA, Castle PE.

J Natl Cancer Inst. 2017 Nov 14. doi: 10.1093/jnci/djx225. [Epub ahead of print]

PMID:
29145648
17.

Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.

Liu AH, Walker J, Gage JC, Gold MA, Zuna R, Dunn ST, Schiffman M, Wentzensen N.

Obstet Gynecol. 2017 Dec;130(6):1218-1225. doi: 10.1097/AOG.0000000000002330.

PMID:
29112672
18.

Smoking and subsequent human papillomavirus infection: a mediation analysis.

Eldridge RC, Pawlita M, Wilson L, Castle PE, Waterboer T, Gravitt PE, Schiffman M, Wentzensen N.

Ann Epidemiol. 2017 Nov;27(11):724-730.e1. doi: 10.1016/j.annepidem.2017.10.004. Epub 2017 Oct 17.

PMID:
29107447
19.
20.

Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial.

Safaeian M, Sampson JN, Pan Y, Porras C, Kemp TJ, Herrero R, Quint W, van Doorn LJ, Schussler J, Lowy DR, Schiller J, Schiffman MT, Rodriguez AC, Gail MH, Hildesheim A, Gonzalez P, Pinto LA, Kreimer AR; Costa Rica HPV Vaccine Trial (CVT) Group.

J Natl Cancer Inst. 2018 Feb 1;110(2). doi: 10.1093/jnci/djx158.

PMID:
28954299
21.

Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.

Demarco M, Lorey TS, Fetterman B, Cheung LC, Guido RS, Wentzensen N, Kinney WK, Poitras NE, Befano B, Castle PE, Schiffman M.

J Low Genit Tract Dis. 2017 Oct;21(4):261-267. doi: 10.1097/LGT.0000000000000343.

22.

ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing Standards.

Waxman AG, Conageski C, Silver MI, Tedeschi C, Stier EA, Apgar B, Huh WK, Wentzensen N, Massad LS, Khan MJ, Mayeaux EJ Jr, Einstein MH, Schiffman MH, Guido RS.

J Low Genit Tract Dis. 2017 Oct;21(4):235-241. doi: 10.1097/LGT.0000000000000336.

PMID:
28953112
23.

ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice.

Wentzensen N, Schiffman M, Silver MI, Khan MJ, Perkins RB, Smith KM, Gage JC, Gold MA, Conageski C, Einstein MH, Mayeaux EJ Jr, Waxman AG, Huh WK, Massad LS.

J Low Genit Tract Dis. 2017 Oct;21(4):230-234. doi: 10.1097/LGT.0000000000000334.

PMID:
28953111
24.

ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice.

Khan MJ, Werner CL, Darragh TM, Guido RS, Mathews C, Moscicki AB, Mitchell MM, Schiffman M, Wentzensen N, Massad LS, Mayeaux EJ Jr, Waxman AG, Conageski C, Einstein MH, Huh WK.

J Low Genit Tract Dis. 2017 Oct;21(4):223-229. doi: 10.1097/LGT.0000000000000338. Review.

PMID:
28953110
25.

Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States.

Wentzensen N, Massad LS, Mayeaux EJ Jr, Khan MJ, Waxman AG, Einstein MH, Conageski C, Schiffman MH, Gold MA, Apgar BS, Chelmow D, Choma KK, Darragh TM, Gage JC, Garcia FAR, Guido RS, Jeronimo JA, Liu A, Mathews CA, Mitchell MM, Moscicki AB, Novetsky AP, Papasozomenos T, Perkins RB, Silver MI, Smith KM, Stier EA, Tedeschi CA, Werner CL, Huh WK.

J Low Genit Tract Dis. 2017 Oct;21(4):216-222. doi: 10.1097/LGT.0000000000000322.

PMID:
28953109
26.

HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis.

Mirabello L, Yeager M, Yu K, Clifford GM, Xiao Y, Zhu B, Cullen M, Boland JF, Wentzensen N, Nelson CW, Raine-Bennett T, Chen Z, Bass S, Song L, Yang Q, Steinberg M, Burdett L, Dean M, Roberson D, Mitchell J, Lorey T, Franceschi S, Castle PE, Walker J, Zuna R, Kreimer AR, Beachler DC, Hildesheim A, Gonzalez P, Porras C, Burk RD, Schiffman M.

Cell. 2017 Sep 7;170(6):1164-1174.e6. doi: 10.1016/j.cell.2017.08.001.

PMID:
28886384
27.

Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records.

Cheung LC, Pan Q, Hyun N, Schiffman M, Fetterman B, Castle PE, Lorey T, Katki HA.

Stat Med. 2017 Sep 30;36(22):3583-3595. doi: 10.1002/sim.7380. Epub 2017 Jun 28.

PMID:
28660629
28.

Preoperative Percutaneous Microwave Ablation of Long Bone Metastases Using a Parallel Medullary Approach for Reduction of Operative Blood Loss.

Cornman-Homonoff J, Miller ZA, Smirniotopoulos J, May BJ, Winokur RS, Pua BB, Schiffman MH.

J Vasc Interv Radiol. 2017 Jul;28(7):1069-1071. doi: 10.1016/j.jvir.2017.03.004. No abstract available.

PMID:
28645506
29.

Why does cervical cancer occur in a state-of-the-art screening program?

Castle PE, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA, Schiffman M.

Gynecol Oncol. 2017 Sep;146(3):546-553. doi: 10.1016/j.ygyno.2017.06.003. Epub 2017 Jun 10.

PMID:
28606721
30.

In response to: Human papillomavirus screening for low and middle-income countries.

Schiffman M.

Prev Med. 2017 Jul;100:297-298. doi: 10.1016/j.ypmed.2017.04.029. Epub 2017 Apr 29. No abstract available.

PMID:
28583663
31.

Assessment of a New Lower-Cost Real-Time PCR Assay for Detection of High-Risk Human Papillomavirus: Useful for Cervical Screening in Limited-Resource Settings?

Fokom Domgue J, Schiffman M, Wentzensen NH, Gage JC, Castle PE, Raine-Bennett TR, Fetterman B, Lorey T, Poitras NE, Befano B, Xie Y, Miachon LS, Dean M.

J Clin Microbiol. 2017 Aug;55(8):2348-2355. doi: 10.1128/JCM.00492-17. Epub 2017 May 17.

32.

Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.

Clarke MA, Luhn P, Gage JC, Bodelon C, Dunn ST, Walker J, Zuna R, Hewitt S, Killian JK, Yan L, Miller A, Schiffman M, Wentzensen N.

Int J Cancer. 2017 Aug 15;141(4):701-710. doi: 10.1002/ijc.30781. Epub 2017 May 26.

PMID:
28500655
33.

Cervical cancer screening: Epidemiology as the necessary but not sufficient basis of public health practice.

Schiffman M.

Prev Med. 2017 May;98:3-4. doi: 10.1016/j.ypmed.2016.12.028. Epub 2017 Feb 6. No abstract available.

PMID:
28279258
34.

Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines.

Schiffman M, Wentzensen N, Khan MJ, Castle PE, Chelmow D, Huh WK, Moscicki AB, Stockdale CK, Darragh TM, Silver M, Guido RS.

J Low Genit Tract Dis. 2017 Apr;21(2):87-90. doi: 10.1097/LGT.0000000000000300. No abstract available.

PMID:
28244885
35.

Pre-operative renal artery embolization and suprarenal IVC filter placement for prevention of fat embolization in renal angiomyolipoma with venous extension.

Cornman-Homonoff J, Li D, Schiffman M.

Clin Imaging. 2017 May - Jun;43:24-27. doi: 10.1016/j.clinimag.2017.01.012. Epub 2017 Jan 26.

PMID:
28167283
36.

Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials.

Tota JE, Struyf F, Merikukka M, Gonzalez P, Kreimer AR, Bi D, Castellsagué X, de Carvalho NS, Garland SM, Harper DM, Karkada N, Peters K, Pope WA, Porras C, Quint W, Rodriguez AC, Schiffman M, Schussler J, Skinner SR, Teixeira JC, Hildesheim A, Lehtinen M; Costa Rica Vaccine Trial and the PATRICIA study groups.

J Natl Cancer Inst. 2017 Jan 28;109(7). pii: djw300. doi: 10.1093/jnci/djw300. Print 2017 Jan.

PMID:
28132019
37.

Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-Year follow-up of the Guanacaste cohort.

Rodríguez AC, Ávila C, Herrero R, Hildesheim A, Sherman ME, Burk RD, Morales J, Alfaro M, Guillén D, Trejos ME, Vargas RM, Torres G, Schiffman M.

Int J Cancer. 2017 Apr 15;140(8):1926-1934. doi: 10.1002/ijc.30614. Epub 2017 Feb 7.

PMID:
28120391
38.

Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18.

Fu Xi L, Schiffman M, Ke Y, Hughes JP, Galloway DA, He Z, Hulbert A, Winer RL, Koutsky LA, Kiviat NB.

Int J Cancer. 2017 Apr 15;140(8):1747-1756. doi: 10.1002/ijc.30594. Epub 2017 Jan 24.

PMID:
28052328
39.

Unexplained gastrointestinal bleed due to arteriobiliary fistula after percutaneous liver biopsy.

Smirniotopoulos J, Barone P, Schiffman M.

Clin Imaging. 2017 Mar - Apr;42:106-108. doi: 10.1016/j.clinimag.2016.11.019. Epub 2016 Dec 5.

PMID:
27936419
40.

Carcinogenic human papillomavirus infection.

Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, Stanley MA, Franceschi S.

Nat Rev Dis Primers. 2016 Dec 1;2:16086. doi: 10.1038/nrdp.2016.86. Review.

41.

Trends in cervical cancer incidence in younger US women from 2000 to 2013.

Beachler DC, Tota JE, Silver MI, Kreimer AR, Hildesheim A, Wentzensen N, Schiffman M, Shiels MS.

Gynecol Oncol. 2017 Feb;144(2):391-395. doi: 10.1016/j.ygyno.2016.11.031. Epub 2016 Nov 26.

42.

Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines.

Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LA, Myers O, Cuzick J, Wentzensen N, Kinney W, Castle PE, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Obstet Gynecol. 2016 Dec;128(6):1248-1257.

43.

Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps.

Marcus PM, Pashayan N, Church TR, Doria-Rose VP, Gould MK, Hubbard RA, Marrone M, Miglioretti DL, Pharoah PD, Pinsky PF, Rendle KA, Robbins HA, Roberts MC, Rolland B, Schiffman M, Tiro JA, Zauber AG, Winn DM, Khoury MJ.

Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1449-1455. Epub 2016 Aug 9.

44.

Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have ≥CIN2.

Schiffman M, Yu K, Zuna R, Terence Dunn S, Zhang H, Walker J, Gold M, Hyun N, Rydzak G, Katki HA, Wentzensen N.

Int J Cancer. 2017 Feb 1;140(3):718-725. doi: 10.1002/ijc.30456. Epub 2016 Oct 17.

45.

The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen.

Silver MI, Schiffman M, Fetterman B, Poitras NE, Gage JC, Wentzensen N, Lorey T, Kinney WK, Castle PE.

Cancer. 2016 Dec 1;122(23):3682-3686. doi: 10.1002/cncr.30277. Epub 2016 Sep 22.

46.

A cohort study of cervical screening using partial HPV typing and cytology triage.

Schiffman M, Hyun N, Raine-Bennett TR, Katki H, Fetterman B, Gage JC, Cheung LC, Befano B, Poitras N, Lorey T, Castle PE, Wentzensen N.

Int J Cancer. 2016 Dec 1;139(11):2606-15. doi: 10.1002/ijc.30375. Epub 2016 Aug 26.

47.

Active Intrabronchial Hemorrhage.

Smirniotopoulos J, Schiffman M.

J Vasc Interv Radiol. 2016 Jul;27(7):1076. doi: 10.1016/j.jvir.2016.03.027. No abstract available.

PMID:
27338500
48.

Control of HPV-associated cancers with HPV vaccination.

Schiffman M, Saraiya M.

Lancet Infect Dis. 2017 Jan;17(1):6-8. doi: 10.1016/S1473-3099(16)30146-3. Epub 2016 Jun 6. No abstract available.

PMID:
27282423
49.

Reply to Letter: Using novel risk stratification statistics to better understand the value of screening tests.

Katki HA, Zhao FH, Hu SY, Zhang Q, Qiao YL, Schiffman M.

Int J Cancer. 2016 Oct 1;139(7):1669. doi: 10.1002/ijc.30192. Epub 2016 Jun 5. No abstract available.

50.

Corrigendum to "A comparison of cervical histopathology variability using whole slide digitized images versus glass slides: experience with a statewide registry" [HumAN PatholOGY 2013;44:2542-2548].

Gage JC, Joste N, Ronnett BM, Stoler M, Hunt WC, Schiffman M, Wheeler CM.

Hum Pathol. 2016 Jun;52:201. doi: 10.1016/j.humpath.2016.04.001. Epub 2016 May 1. No abstract available.

Supplemental Content

Loading ...
Support Center